Showing results (531-540 of 586) with videos related to
Sort By:
Pageof 59
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.Journal of the American College of Cardiology|April 23, 2003
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic TrialRobert P Giugliano, Matthew T Roe, Robert A Harrington, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2006
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removalWarren J Cantor, Kenneth W Mahaffey, Zhen Huang, et al.JAMA|September 1, 2004
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trialJames A de Lemos, Michael A Blazing, Stephen D Wiviott, et al.American Heart Journal|August 17, 2004
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen, Kenneth W Mahaffey, Richard C Becker, et al.Circulation. Heart Failure|June 18, 2013
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HFZubin J Eapen, Shelby D Reed, Yanhong Li, et al.The New England Journal of Medicine|April 1, 2009
Early versus delayed, provisional eptifibatide in acute coronary syndromesRobert P Giugliano, Jennifer A White, Christoph Bode, et al.JACC. Heart Failure|December 3, 2014
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trialW H Wilson Tang, Matthias Dupont, Adrian F Hernandez, et al.Heart Rhythm|May 17, 2014
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.Pageof 59